Search results for "amines"

showing 10 items of 664 documents

Pineal 'synaptic' ribbons in sympathectomized rats.

1989

The melatonin metabolism in the mammalian pineal gland is under the clear influence of sympathetic fibers originating in the superior cervical ganglia (SCG). Previous studies suggested that also pineal ‘synaptic’ ribbons (SR) are regulated by the gland’s sympathetic innervation. To gain more insight into the mechanisms involved SR numbers were determined in adult rats which were chemically sympathectomized as newborns by injection of 6-hydroxydopamine (6-OHDA). In control animals (saline injections), a clear day/night difference in the number of SR is present. In sympathectomized animals SR are higher in number throughout the 24-hour cycle but are not significantly elevated at night. The pr…

medicine.medical_specialtyHistologymedicine.medical_treatmentBiologyPineal GlandPineal glandHydroxydopaminesInternal medicinemedicineAnimalsSalineOrganellesSympathectomy ChemicalRats Inbred StrainsRatsMicroscopy Electronmedicine.anatomical_structureEndocrinologySympathectomyPeripheral nervous systemCervical gangliaUltrastructureFemaleAnatomyIntracellularEndocrine glandActa anatomica
researchProduct

Clinical Benefits of Early Triptan Therapy for Migraine

2004

The introduction of the triptans brought advances in achieving complete and sustained pain resolution in migraine patients, compared with non-migraine-specific treatments. However, sustained pain-free rates for triptans recorded in many clinical trials are still relatively low. This may be due to study participants being treated late into the attack, when pain is already moderate or severe. Studies with almotriptan have shown that efficacy is enhanced when treatment is given early in a migraine attack while pain is still mild, compared with later administration when pain intensity is greater. Developments in our understanding of migraine pathophysiology provide a rationale for this phenome…

medicine.medical_specialtyIndolesCentral sensitizationMigraine DisordersTriptans03 medical and health sciences0302 clinical medicinePatient satisfactionIntervention (counseling)AlmotriptanSecondary PreventionmedicineHumans030212 general & internal medicinePractice Patterns Physicians'Intensive care medicineAnalgesicsClinical Trials as TopicEvidence-Based Medicinebusiness.industryDisease progressionGeneral Medicinemedicine.diseaseTryptaminesSerotonin Receptor AgonistsClinical trialTreatment OutcomeMigrainePatient SatisfactionAcute DiseaseDisease ProgressionPhysical therapyNeurology (clinical)businessAttitude to Health030217 neurology & neurosurgerymedicine.drugCephalalgia
researchProduct

Hemodynamic effects of dobutamine in children with cardiovascular failure.

1982

The effect of dobutamine, a synthetic catecholamine, was studied in 12 patients aged one day to 14 years with low cardiac output syndromes. After initial stabilization of the patients dobutamine was administered by continuous infusion in a dosage of 7.5 or 10 μg/kg/min. Heart rate, cardiac output (using thermodilution technique and/or pulse contour method), mean systemic and mean pulmonary artery pressures were determined before and after the dobutamine infusion. Systemic and pulmonary vascular resistances, cardiac index and stroke volume index were calculated. Cardiac output and cardiac index increased significantly in every patient, whereas the heart rate changed only slightly, suggesting…

medicine.medical_specialtyMean arterial pressureCardiac outputAdolescentCardiac indexHemodynamicsBlood PressurePulmonary ArteryCatecholaminesHeart RateInternal medicinemedicine.arteryDobutamineHeart ratemedicineHumansCardiac OutputChildHeart Failurebusiness.industryHemodynamicsInfant NewbornInfantStroke VolumeStroke volumeAnesthesiaPediatrics Perinatology and Child HealthPulmonary arteryCardiologyDobutamineVascular Resistancebusinessmedicine.drugEuropean journal of pediatrics
researchProduct

Neuronal and extraneuronal uptake and efflux of catecholamines in the isolated rabbit heart

1974

1. Isolated rabbit hearts were perfused with (−)-noradrenaline, (−)-adrenaline and (±)-isoprenaline for various time periods (1–180 min) and then washed with an amine-free medium. The venous concentration of the amine was estimated fluorimetrically during the infusion and after its end, to study removal and efflux, respectively. 2. In untreated hearts and after pretreatment with reserpine the removal had a constant rate over 20–60 min. After pretreatment with pargyline to block monoamine oxidase (MAO), however, the removal of noradrenaline declined exponentially to zero. Inhibition of the neuronal uptake (desipramine) and chemical sympathectomy (6-hydroxydopamine) abolished the removal of n…

medicine.medical_specialtyMonoamine Oxidase InhibitorsReserpineTime FactorsEpinephrineMonoamine oxidaseStimulationModels BiologicalHydroxydopaminesNorepinephrineCatecholaminesHeart RateDesipramineIsoprenalineInternal medicinemedicineAnimalsNeuronsPharmacologyChemistryMyocardiumDesipramineIsoproterenolGeneral MedicineCompartment (chemistry)ReserpinePargylinePerfusionEndocrinologyPargylineRabbitsEffluxHalf-Lifemedicine.drugNaunyn-Schmiedeberg's Archives of Pharmacology
researchProduct

Migraine and cluster headache – the common link

2018

Abstract Although clinically distinguishable, migraine and cluster headache share prominent features such as unilateral pain, common pharmacological triggers such glyceryl trinitrate, histamine, calcitonin gene-related peptide (CGRP) and response to triptans and neuromodulation. Recent data also suggest efficacy of anti CGRP monoclonal antibodies in both migraine and cluster headache. While exact mechanisms behind both disorders remain to be fully understood, the trigeminovascular system represents one possible common pathophysiological pathway and network of both disorders. Here, we review past and current literature shedding light on similarities and differences in phenotype, heritability…

medicine.medical_specialtyNeurologyCluster headacheImplantable Neurostimulators/statistics & numerical dataPain medicineCalcitonin Gene-Related PeptideDeep Brain StimulationMigraine DisordersNitroglycerin/adverse effectsHypothalamuslcsh:MedicineTriptansReviewCalcitonin gene-related peptideBioinformatics03 medical and health sciencesNitroglycerin0302 clinical medicinemedicineHumans030212 general & internal medicineTryptamines/pharmacologyMigraineTrigeminovascular systembusiness.industryNeuromodulationCluster Headache/bloodCluster headacheAnti-CGRP (receptor) monoclonal antibodies – mAbsMigraine Disorders/bloodTrigeminovascular systemlcsh:RGeneral MedicineCalcitonin gene-related peptide (CGRP)medicine.diseaseDeep Brain Stimulation/statistics & numerical dataNeuromodulation (medicine)Tryptamines3. Good healthCalcitonin Gene-Related Peptide/antagonists & inhibitorsAnesthesiology and Pain MedicineImplantable NeurostimulatorsMigraineNeurology (clinical)business030217 neurology & neurosurgerymedicine.drugThe Journal of Headache and Pain
researchProduct

A PRISMA-compliant systematic review of the endpoints employed to evaluate symptomatic treatments for primary headaches

2018

Abstract Background Primary headache are prevalent and debilitating disorders. Acute pain cessation is one of the key points in their treatment. Many drugs have been studied but the design of the trials is not usually homogeneous. Efficacy of the trial is determined depending on the selected primary endpoint and usually other different outcomes are measured. We aim to critically appraise which were the employed outcomes through a systematic review. Methods We conducted a systematic review of literature focusing on studies on primary headache evaluating acute relief of pain, following the PRISMA guideline. The study population included patients participating in a controlled study about sympt…

medicine.medical_specialtyNeurologyHeadache Disorders Primaryendpointspractice guidelines as topiclcsh:MedicineTriptansPlacebopatient complianceanti-inflammatory agentsnon-steroidal03 medical and health sciences0302 clinical medicineQuality of lifeInternal medicineprimarymedicineClinical endpoint030212 general & internal medicinehumansdisabled personsclinical trialsnon-steroidal anti-inflammatorybusiness.industryAnti-Inflammatory Agents Non-Steroidallcsh:RtryptaminesCorrectionacuteGeneral MedicineGuidelineacute; clinical trials; endpoints; non-steroidal anti-inflammatory; primary headaches; prisma-guidelines; triptans; anti-inflammatory agents non-steroidal; chronic disease; disabled persons; headache disorders primary; humans; patient compliance; practice guidelines as topic; treatment outcome; tryptamines; quality of lifemedicine.diseasetriptansClinical trialAnesthesiology and Pain Medicineheadache disordersMigrainequality of lifetreatment outcomeprimary headachesNeurology (clinical)prisma-guidelinesbusinesschronic disease030217 neurology & neurosurgeryResearch Articlemedicine.drug
researchProduct

Focal elevation of liver microsomal epoxide hydrolase in early preneoplastic stages and its behaviour in the further course of hepatocarcinogenesis.

1981

Abstract Treatment of rats with N-nitrosomorpholine (NNM) for 7 weeks led to a focal increase in liver microsomal epoxide hydrolase (EH) as early as 2 weeks after withdrawal of the carcinogen. This treatment also leads to hyperplastic nodules and liver tumors, but much later. At the same early time point, ATPase activity was decreased in the same islands. Most of these areas already had increased γ-glutamyltranspeptidase activity. The increase in EH at this early time point was more distinct than the decrease in ATPase which has thus far been considered a suitable marker of the earliest stages in hepatocarcinogenesis. The focal increase in EH was also observed in all benign hepatomas, but n…

medicine.medical_specialtyNitrosaminesATPaseBiophysicsBiochemistryLiver Neoplasms ExperimentalInternal medicinemedicineAtpase activityAnimalsMolecular BiologyCarcinogenAdenosine TriphosphatasesEpoxide HydrolasesbiologyLiver NeoplasmsCell Biologygamma-GlutamyltransferaseRatsEndocrinologyLiverMicrosomal epoxide hydrolasebiology.proteinMicrosomes LiverFemaleRabbitsHyperplastic nodulesPrecancerous ConditionsBiochemical and biophysical research communications
researchProduct

Histamine-sensitive adenylate cyclase of human gastric mucosa: a model for H2-receptor excitation.

1978

Recent studies revealed that human gastric mucosa contains a histamine-sensitive adenylate cyclase which is almost completely localized within the acid-secreting area of the stomach. In an attempt to further characterize the effector system of histamine’s action, we compared the effects of H 1 — and H 2-receptor agonists upon the adenylate cyclase in human fundic gastric mucosa.

medicine.medical_specialtyNucleotidase activityAdenylate kinaseIn Vitro TechniquesCyclasechemistry.chemical_compoundHistamine H2 receptorInternal medicinemedicineGastric mucosaEthylaminesHumansheterocyclic compoundsPharmacology (medical)Receptors Histamine H2Receptors Histamine H1Pharmacologybusiness.industryEffectorStomachMethylhistaminesdigestive system diseasesStimulation Chemicalmedicine.anatomical_structureEndocrinologychemistryGastric MucosaReceptors HistaminebusinessHistamineResearch ArticleAdenylyl CyclasesHistamine
researchProduct

Interrelation of peptidergic innervation with mast cells and ED1-positive cells in rat thymus

1991

The peptidergic innervation of rat thymus has been investigated by immunohistochemical methods, focusing on the spatial interrelationship of peptidergic nerve fibers with mast cells and macrophages in the rat. An antiserum directed against the protein gene product 9.5 (PGP 9.5) regarded as a pan-neuronal marker revealed a rich innervation, especially in the subcapsular cortex, in interlobular septa, and of the vasculature in the cortex and the corticomedullary boundary. A minor proportion of PGP 9.5-immunoreactive (ir) fibers supplied the thymic parenchyma. The main component of peptidergic innervation consisted of fibers costaining for tachykinins (TKs) and calcitonin gene-related peptide …

medicine.medical_specialtyPathologyNeuroimmunomodulationImmunologyVasoactive intestinal peptideConnective tissueNerve fiberThymus GlandBiologyCalcitonin gene-related peptideBehavioral NeuroscienceCatecholaminesNerve FibersInternal medicineCortex (anatomy)medicineAnimalsMast CellsGalaninEndocrine and Autonomic SystemsMacrophagesNeuropeptidesAntibodies MonoclonalCell DifferentiationRats Inbred StrainsMast cellRatsReceptors NeurotransmitterEndocrinologymedicine.anatomical_structurePeripheral nervous systemUbiquitin ThiolesteraseBiomarkersBrain, Behavior, and Immunity
researchProduct

The concentration of para-phenylenediamine (PPD) for routine patch testing in a standard series needs to be redefined

2005

medicine.medical_specialtyPediatricsDose-Response Relationship Drugbusiness.industryDermatologyPatch TestsPhenylenediaminesPara phenylenediamineDermatologyPatch testing030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineGermany030220 oncology & carcinogenesisDermatitis Allergic ContactmedicineHumansImmunology and AllergyColoring AgentsbusinessContact Dermatitis
researchProduct